Patrick Soon-Shiong congratulates Prasad on FDA CBER appointment
@DrPatSoonShiong: Soon-Shiong congratulates Prasad
Patrick Soon-Shiong congratulated Dr. Vinay Prasad on his recent appointment as the head of the FDA Center for Biologics Evaluation and Research (CBER).
This high-profile endorsement comes amidst Soon-Shiong's call for new leadership within the FDA, emphasizing the need for fresh perspectives to address current challenges. With a track record of over 50 approvals for both novel drugs and generics, such as Abraxane and Anktiva, Soon-Shiong's commendation also acknowledges Prasad's future role in the advancement of cancer treatments.
Soon-Shiong, a prominent figure in the pharmaceutical industry, stressed the importance of criticism aimed at existing structures: ''Criticizing old guard at FDA takes courage. But we have to on behalf of patients,'' he stated in his tweet, underscoring the importance of ongoing innovation and patient-centric approaches in medical research and regulatory affairs.
Loading...
